Autres langues H.U. Group Holdings, Inc.

Actions

4544

JP3822000000

Temps Différé Japan Exchange Autres places de cotation 08:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
2 501 ^JPY	-0,48 %		-0,08 %	-6,10 %

10/05	H.U. Group Holdings, Inc. présente ses prévisions de résultats consolidés pour l'exercice fiscal se terminant le 31 mars 2025	CI
26/04	H.U. Group Holdings, Inc. révise ses prévisions de résultats consolidés pour l'exercice fiscal se terminant le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

H.U. Group Holdings, Inc. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on May 28, 2024; Provides Dividend Guidance for the Second Quarter-End and Fiscal Year Ending March 31, 2025	10/05
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2025	10/05
H.U. Group Cuts Forecasts for Fiscal Year Ended March 31	02/05
H.U. Group Holdings, Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	26/04
H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Executive Officer	26/04
H.U. Group Holdings, Inc. Announces Retirement of Atsuko Murakami as Chief Financial Officer	26/04
H.U Unit Fujirebio Diagnostics Partners Beckman Coulter in Neurodegenerative Diseases Field	13/03
Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics	13/03
H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems	22/12
Japanese Shares Rebound After Inflation Data, BoJ Rate Outlook	22/12
H.U. Group to Issue Stock Options to Directors, Employees	22/12
H.U. Group to Grant Share Options to Staff	20/11
H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024	09/11
H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index	18/09/23
Recent DOJ Settlement With NextGen Highlights Continued Enforcement Focus On Electronic Health Records Technology Vendors	07/08/23
H.U. Group Holdings' Fiscal Full-Year Profit Falls 47%	17/05/23
H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024	16/05/23
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2024	16/05/23
H.U. Group Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23
H.U. Group Holdings Inc. - Fujirebio further extends its fully automated blood-based biomarker portfolio with the fully automated Lumipulse G ApoE4 and Lumipulse G Pan-ApoE assays for Research Use Only	03/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues H.U. Group Holdings, Inc.

Actions

4544

JP3822000000

Autres langues

Filtres